InvestorsHub Logo
Followers 30
Posts 2208
Boards Moderated 0
Alias Born 12/13/2016

Re: Talon38 post# 124944

Monday, 10/16/2017 3:54:54 PM

Monday, October 16, 2017 3:54:54 PM

Post# of 464022
Apologize, Biogen has apparently taken down their "Lab Video" for whatever reason however, I trust that many you saw Biogen's top scientist, Dr Sandrock, and his four other colleagues expound on the importance of remyelination to M/S treatment.

On a another point concerning M/S, did we get any feedback on Dr Klamer's presentation in September? I may have been offline when we did.

-----

"The scientific rationale, preclinical data, and clinical development path of ANAVEX 2-73 as a novel treatment strategy for Rett Syndrome, Parkinson’s Disease, and Multiple Sclerosis will be discussed in more detail. This presentation will explore the links between preclinical findings and clinical trial development trajectory in our ongoing translational research efforts."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News